According to the research report titled ‘Global Antihypertensive Drugs Market Size study, by Therapeutic Class (Diuretics, Angiotensin-Converting Enzyme (ACE) Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2020-2027’ available with Market Study Report, global antihypertensive drugs market was worth USD 23.2 million in the year 2019 and is projected to register a CAGR of 3.1% over the duration of 2020-2027.
 

As per the report, rising geriatric population coupled with escalating cases of hypertension across the world are key factors driving the growth of global antihypertensive drugs market. In fact, Framingham Heart Study claims that the possibility of a person developing hypertension is directly proportional to the person’s age. Moreover, roughly 75% of women and 65% of men develop hypertension by the age of 70.
 

For the record, antihypertensive drugs are primarily prescribed to patients suffering from hypertension, which is a leading cause of heart conditions including dementia, heart attacks, and heart failure.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2764835/
 

Rising prevalence of cardiovascular disorders such as myocardial infarction and strokes has impelled the demand for hypertension treatment into various medical programs. Besides this, development of a wide variety of antihypertensive drugs such as dihydropyridine calcium-channel blockers, beta-blockers (beta-adrenoceptor antagonists), and thiazide diuretics among others is further aiding the market expansion.
 

These drugs help in reducing blood pressure levels as well as in preventing other health complications pertaining to high blood pressure, which in turn is augmenting the expansion of global antihypertensive drugs market.
 

Furthermore, the outbreak of the COVID-19 pandemic has compelled governments across the globe to mandate the use of drugs in order to reduce or prevent respiratory problems among patients, thereby proliferating the sales of antihypertensive drugs. On the contrary, rising concerns regarding side-effects associated with these drugs may inhibit the expansion of worldwide antihypertensive drugs market.
 

As per the regional analysis, North America presently accounts for a significant market share, primarily due to favorable initiatives taken by major companies and increased pervasiveness of hypertension.
 

On the other hand, Asia-Pacific antihypertensive drugs market is projected to grow substantially through 2027, owing to increasing geriatric population coupled with rising occurrences of heart failure and cardiac arrests.
 

The competitive landscape of global antihypertensive drugs market is defined by major players including Novartis International AG, Sanofi S.A., Daiichi Sankyo Co. Ltd., AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Pfizer Inc., Bayer AG, Johnson and Johnson, Merck & Co. Inc., and Boehringer Ingelheim International GmbH among others.